Jean‐Pierre Armand
- Oncology top 0.5%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 1%
- Surgery top 5%
- Cancer Research top 2%
- Co-authors
- Éric RaymondSandrine FaivreCaroline RobertMichel DucreuxKarina VeraJean‐Charles SoriaM ForniEsteban Cvitkovic
- Topics
- Cancer Treatment and Pharmacology (30 papers)Cancer therapeutics and mechanisms (27 papers)Colorectal Cancer Treatments and Studies (20 papers)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Jean‐Pierre Armand
158 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 3.7k
- Molecular Biology 2.6k
- Pulmonary and Respiratory Medicine 2.1k
- Surgery 865
- Cancer Research 827
Countries citing papers authored by Jean‐Pierre Armand
This map shows the geographic impact of Jean‐Pierre Armand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Armand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Armand more than expected).
Fields of papers citing papers by Jean‐Pierre Armand
This network shows the impact of papers produced by Jean‐Pierre Armand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Armand. The network helps show where Jean‐Pierre Armand may publish in the future.
Co-authorship network of co-authors of Jean‐Pierre Armand
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Armand. A scholar is included among the top collaborators of Jean‐Pierre Armand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Armand. Jean‐Pierre Armand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 109 | |
| 3 | Phase I (3 hour infusion every 3 weeks) escalating dose study of intravenous ES-285 in patients with advanced malignant solid tumors | 3 |
| 4 | 39 | |
| 5 | 45 | |
| 6 | 59 | |
| 7 | Récidives dans les tumeurs gliales : place de la radiothérapie | 14 |
| 8 | 67 | |
| 9 | Les carcinomes du nasopharynx | 2 |
| 10 | 42 | |
| 11 | 4 | |
| 12 | Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials. | 125 |
| 13 | CPT-11: the European clinical development. | 2 |
| 14 | 21 | |
| 15 | 11 | |
| 16 | 4 | |
| 17 | 32 | |
| 18 | [Harlequin fetus treated with etretin (RO 10-1670)]. | 3 |
| 19 | 25 | |
| 20 | Evidence for the importance of 5'-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometry. | 38 |
About Jean‐Pierre Armand
Jean‐Pierre Armand is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 161 papers that have together received 6.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (30 papers), Cancer therapeutics and mechanisms (27 papers) and Colorectal Cancer Treatments and Studies (20 papers). The work is most often cited by research in Otorhinolaryngology (613 citations), Oncology (3.7k citations) and Pulmonary and Respiratory Medicine (2.1k citations). Jean‐Pierre Armand has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Éric Raymond, Sandrine Faivre, Caroline Robert, Michel Ducreux, Karina Vera, Jean‐Charles Soria, M Forni, Esteban Cvitkovic, Nathalie Lassau and Nicoletta Brega. Their work appears in journals such as Science, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.